Medicare drug coverage
Xiidra in Wyoming: 2027 Part D coverage
5 of 13 Part D plans offered in Wyoming (38%) list Xiidra on their 2027 formulary, the plan's list of covered drugs (down 25 points from 2026). 100% of those require prior authorization, step therapy, or a quantity limit. Plan counts include both Medicare Advantage plans with drug coverage (4 MA-PD) and stand-alone drug plans (9 PDP).
License: a US government work, in the public domain (Public Domain Mark 1.0).
For pharmacies and agencies: check a whole drug list against 2027 formularies.
Upload your patient list or your book of clients and Rivvi checks each drug against the CMS 2027 formulary files, plan by plan, so you see tier changes and new limits before the next refill or open enrollment. Free to start. HIPAA BAA included.
Every 2027 plan in Wyoming
Each Part D plan offered in Wyoming, with Xiidra's 2026 and 2027 tier and its 2027 limits. A tier is the cost level a plan puts a drug on; a lower tier usually costs less. Enter a ZIP to see only the plans offered in that county.
PA is prior authorization (the plan must approve it first), ST is step therapy (try another drug first), and QL is a quantity limit. D-SNP, C-SNP, and I-SNP are Special Needs Plans: for people with both Medicare and Medicaid, with certain chronic conditions, or who live in a nursing home or need that level of care. Plans are listed by plan ID.
| Plan | Plan ID | Type | 2026 tier | 2027 tier | 2027 PA / ST / QL | Change |
|---|---|---|---|---|---|---|
| HumanaChoice H5216-048 (PPO) | H5216-048-000 | MA-PD (PPO) | Not listed | Not listed | Not listed | Not listed either year |
| HumanaChoice H5525-054 (PPO) | H5525-054-000 | MA-PD (PPO) | Not listed | Not listed | Not listed | Not listed either year |
| WyoBlue Advantage Essential PPO (PPO) | H9326-001-000 | MA-PD (PPO) | Tier 4 | Tier 4 | QL | No change |
| WyoBlue Advantage Enhanced PPO (PPO) | H9326-002-000 | MA-PD (PPO) | Tier 4 | Tier 4 | QL | No change |
| Wellcare Classic (PDP) | S4802-089-000 | PDP | Tier 3 | Tier 2 | QL | Tier 3 to 2 |
| Wellcare Value Script (PDP) | S4802-158-000 | PDP | Tier 3 | Tier 2 | QL | Tier 3 to 2 |
| HealthSpring Assurance Rx (PDP) | S5715-043-000 | PDP | New plan ID | Not listed | Not listed | New plan ID in 2027 |
| MedicareBlue Rx Standard (PDP) | S5743-001-000 | PDP | Tier 3 | Not listed | Not listed | No longer listed |
| Humana Basic Rx Plan (PDP) | S5884-145-000 | PDP | Not listed | Not listed | Not listed | Not listed either year |
| Humana Premier Rx Plan (PDP) | S5884-171-000 | PDP | Not listed | Not listed | Not listed | Not listed either year |
| Humana Value Rx Plan (PDP) | S5884-204-000 | PDP | Not listed | Not listed | Not listed | Not listed either year |
| AARP Medicare Rx Saver from UHC (PDP) | S5921-370-000 | PDP | Not listed | Not listed | Not listed | Not listed either year |
| AARP Medicare Rx Preferred from UHC (PDP) | S5921-406-000 | PDP | Tier 4 | Tier 4 | QL | No change |
Data only, not plan advice. Confirm on Medicare.gov Plan Finder or 1-800-MEDICARE.
Wyoming compared with the nation
100% of the 13 Part D plans offered in Wyoming leave Xiidra off the 2027 formulary or restrict it, against 82% nationally (18 points higher). Wyoming is tied with 6 other states for rank 1 of 51, at 100% of plans restricting or leaving it off. A plan offered in several states counts in each.
2027 compared with 2026
| Measure | 2026 | 2027 | Change |
|---|---|---|---|
| Part D plans in the file | 19 | 13 | -6 |
| Plans that list it | 12 (63%) | 5 (38%) | -25 points |
| Prior authorization (of plans that list it) | 1 (8%) | 0 (0%) | -8 points |
| Step therapy (of plans that list it) | 0 (0%) | 0 (0%) | no change |
| Quantity limit (of plans that list it) | 12 (100%) | 5 (100%) | no change |
| Any of the three (of plans that list it) | 12 (100%) | 5 (100%) | no change |
| Not listed or restricted (of all plans) | 19 (100%) | 13 (100%) | no change |
Formulary tier
| Tier | 2026 plans | 2027 plans |
|---|---|---|
| Tier 2 | 0 (0%) | 2 (40%) |
| Tier 3 | 5 (42%) | 0 (0%) |
| Tier 4 | 7 (58%) | 3 (60%) |
Plan by plan, 2026 to 2027
| Plan by plan | Plans |
|---|---|
| Same plan ID in both years | 12 |
| Listed it in 2026, not in 2027 | 1 (8%) |
| Listed it in 2027, not in 2026 | 0 (0%) |
| Moved it to a higher tier | 0 (0%) |
| Moved it to a lower tier | 2 (17%) |
| Added prior authorization | 0 (0%) |
| Added step therapy | 0 (0%) |
| Added a quantity limit | 0 (0%) |
| Added at least one of the three | 0 (0%) |
| Removed at least one of the three | 0 (0%) |
| Plan IDs new in 2027 | 1 |
| 2026 plan IDs not in the 2027 file | 6 |
The CMS summary has no count of tier moves down, so "Moved it to a lower tier" is counted from the plan rows on this page: plans with the same plan ID in both years that list Xiidra both years.
Plans that list Xiidra fell from 12 to 5; 1 of the 12 plans offered in both years stopped listing it. The rest of the fall comes from the plan list. 6 plan IDs offered here in 2026 are not in the 2027 file, and 5 of them listed it. 1 plan ID is new in 2027, and it does not list it. 1 plan ID offered here in 2026 is offered only in other states in 2027, and it listed it.
Same plan ID in both years (12) plus 2026 plan IDs not in the 2027 file (6) add up to 18, not the 19 plans offered in Wyoming in 2026, because some plans are offered in different states in 2026 and 2027. 1 plan ID offered here in 2026 is offered only in other states in 2027, so it counts in neither row.
Xiidra in other states
- Alabama65% restrict or leave off, -10 pointsAL
- Alaska100% restrict or leave off, no changeAK
- Arizona74% restrict or leave off, -5 pointsAZ
- Arkansas83% restrict or leave off, no changeAR
- California92% restrict or leave off, +17 pointsCA
- Colorado80% restrict or leave off, -8 pointsCO
- Connecticut74% restrict or leave off, -5 pointsCT
- Delaware88% restrict or leave off, -5 pointsDE
- District of Columbia95% restrict or leave off, -1 pointDC
- Florida80% restrict or leave off, -4 pointsFL
- Georgia89% restrict or leave off, -3 pointsGA
- Hawaii52% restrict or leave off, -8 pointsHI
- Idaho93% restrict or leave off, +11 pointsID
- Illinois76% restrict or leave off, -5 pointsIL
- Indiana77% restrict or leave off, -5 pointsIN
- Iowa83% restrict or leave off, -2 pointsIA
- Kansas87% restrict or leave off, -5 pointsKS
- Kentucky89% restrict or leave off, -3 pointsKY
- Louisiana82% restrict or leave off, -10 pointsLA
- Maine85% restrict or leave off, -2 pointsME
- Maryland65% restrict or leave off, -22 pointsMD
- Massachusetts54% restrict or leave off, no changeMA
- Michigan85% restrict or leave off, -6 pointsMI
- Minnesota98% restrict or leave off, -1 pointMN
- Mississippi85% restrict or leave off, +1 pointMS
- Missouri82% restrict or leave off, -8 pointsMO
- Montana100% restrict or leave off, +3 pointsMT
- Nebraska80% restrict or leave off, -5 pointsNE
- Nevada100% restrict or leave off, +5 pointsNV
- New Hampshire76% restrict or leave off, -24 pointsNH
- New Jersey92% restrict or leave off, no changeNJ
- New Mexico82% restrict or leave off, no changeNM
- New York77% restrict or leave off, -6 pointsNY
- North Carolina80% restrict or leave off, -9 pointsNC
- North Dakota100% restrict or leave off, no changeND
- Ohio77% restrict or leave off, -3 pointsOH
- Oklahoma85% restrict or leave off, -5 pointsOK
- Oregon71% restrict or leave off, -13 pointsOR
- Pennsylvania85% restrict or leave off, -3 pointsPA
- Rhode Island86% restrict or leave off, -1 pointRI
- South Carolina89% restrict or leave off, +1 pointSC
- South Dakota100% restrict or leave off, +7 pointsSD
- Tennessee71% restrict or leave off, -8 pointsTN
- Texas85% restrict or leave off, -4 pointsTX
- Utah85% restrict or leave off, -3 pointsUT
- Vermont86% restrict or leave off, +1 pointVT
- Virginia88% restrict or leave off, -4 pointsVA
- Washington78% restrict or leave off, -15 pointsWA
- West Virginia100% restrict or leave off, no changeWV
- Wisconsin96% restrict or leave off, no changeWI
About this data
A plan here is one Part D plan as the CMS formulary files list it: contract, plan, and segment. That covers Medicare Advantage plans with drug coverage and stand-alone drug plans. A plan lists a drug when its formulary has a row for any RxNorm product of that name. When it has several, the row with the lowest tier is the one counted, and restricted means that row has prior authorization, step therapy, or a quantity limit.
A plan with no row for the drug counts as not listing it. That can be a product the file codes another way, so read a low count as a lookup result, not a coverage decision. A state counts every plan the CMS landscape file offers there. Parent organizations are named as CMS names them. The drug list is the top 200 by total Part D spending.
Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page
Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page
Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page
Source: CMS CY2026 landscape file, as of September 25, 2025. Publisher page
Source: CMS Medicare Part D Spending by Drug, 2024 data, as of June 25, 2026. Publisher page
Source: US Census Bureau 2020 ZCTA to county relationship file (ZIP lookup), as of December 9, 2021. Publisher page